Contents

This info is permanently being updated

MODULE 1 | INNOVATION IN BIOTECH

modules_white.jpgM1/DAY1
FRI 14 SEP

startup__0002_Miguel Santos.jpg

Miguel Santos

Short CV
Miguel Santos holds a BSc and a MSc degree in Biochemistry from Old Dominion University, VA, USA; a PhD in Molecular Biology from ITQB/UNL, PT; a Post-Doctorate in Genomics, UA, PT; a proficiency degree in Project Management (PMI Intl.), UAL, PT; a Mini-MBA in Global Biopharma Entrepreneurship, Rutgers University, NJ, USA; and a MBA from the Institute of Business Management (IBM) Lisbon. Miguel has occupied several managing positions within academy and industry. Recently, as COO at ECBio S.A., Miguel coordinated several aspects of Advanced Therapy Medicinal Product (ATMP) development and was responsible for the implementation and maintenance of the Research, Development and Innovation Management System according to the NP 4457:2007 (Intl. standard based on the Oslo Manual, Eurostat/OCDE, 2005). Miguel is currently an Affiliated Researcher at the Animal Science Studies Centre (CECA/ICETA - UPorto) and iMED (FF.ULisboa), and an Invited Principal Investigator at ITQB NOVA, where he coordinates the StartUp Research Program, in collaboration with the Venture Lab from NOVA SBE.  Miguel provides consultancy in Open Innovation and New Product Development to Biotech StartUps and is presently a member of the Advanced Therapies Evaluation Committee, at INFARMED; and an Executive Board Member of the Portuguese Society for Stem Cell and Stem Cell-Based Therapies.

Topics
During the first day at the StartUp Research Program, we shall define Innovation according to the OECD Oslo Manual, Eurostat/OCDE, 2005, and analyse the advantages of an Open Innovation model and a Front-End view over other more conservative models of value creation. We shall analyse how we can apply the Open and Front-End Innovation processes to scientific research and learn how to separate the Innovation concept from Invention and Discovery. We shall then take a general view into the rainbow classification of the several faces of Biotechnology and identify several trendy value propositions (either product or service) that exist across the many colours of Biotech. Finally, we shall exercise the very first step of the Innovation Process Ideation. Indeed, creativity sparkles Innovation. You can create conditions to stimulate creativity by whirling around several well-established strategies, such as programmed brainstorming sessions or pre-scheduled retreats. However, Ideation is triggered when it is least expected, often during atypical circumstances …

modules_white.jpgM1/DAY1
FRI 14 SEP
starup_0001_Miguel_Pinto.jpg Miguel Pinto

Short CV

Miguel graduated in Economics from the Instituto Superior de Economia e Gestão (ISEG), Ulisboa. Presently, Miguel is a Partner- Advisory Services at Ernst & Young, in Brazil, and has over fifteen years of professional experience. With a background in consultancy and in the front line of different industries, Miguel has been an important player within the organizations he has worked for, where he embraced a broad range of projects from setting high-level strategic direction and conducting enterprise-wide reorganizations to redesigning core processes. Before joining EY, Miguel was Managing Director for Strategos’ offices in Brazil and Portugal. He took part in projects identifying new business strategies and building innovation capabilities in several different industries - Telco, Media Entertainment, retail, football, construction or aeronautics, etc. - by developing a systemic approach to innovation or identifying new growth platforms and new business models for his clients. Miguel is an invited teacher for the Advanced Program in Entrepreneurship and Innovation Management at Universidade Católica, Lisbon, Portugal.

Topics
In a very demanding competitive landscape characterized by a VUCA (Volatile Uncertain Complex and Ambiguous) environment, companies and professionals in general must develop strong capabilities to innovate continuously. Agenda for discussion: 1. The innovation Imperative – Why?, 2. The Innovation Myths - Lessons learnt about Innovation as a competence, 3 - Key principles for Innovation, 4 - Q&A.

modules_purple.jpgM1/DAY2
SAT 15 SEP

starup_0003_ligia_gata.jpg Lígia Gata

Short CV

With a PhD in Agronomic and Environmental Chemistry and MSc in Molecular Biology and Genetics, Lic. In Veterinary Sciences, Ligia was previously a researcher for approximately 10 years.

She has been working in Intellectual Property since 1999, first as Patent Examiner and PT delegate in several international IP forums, such as in WIPO, EU, EPO and WTO, then as Director of the Patent Dep. In a private practice IP-multinational company and later as Patent Counsel in a German biotech company. More recently, Ligia has been working as IP & Innovation Manager at Megaingenium, her own IP –Company.

She is European Patent Attorney (PQ), PT National Representative, and Representative before EUIPO and WIPO.

Topics
available soon

modules_purple.jpgM1/DAY2
SAT 15 SEP
starup_0011_cristina_spereira.jpg Cristina Silva Pereira

Short CV

Cristina Silva Pereira is an Associate Professor at ITQB NOVA (since 2017), where she leads her research group (since 2008). She is also Invited Researcher at the University of the West of Scotland (UK). Her research focus has always been problem-driven, often leading her to cross perceived discipline boundaries, such as those of Chemistry and Microbiology. She studied Applied Chemistry - Biotechnology (FCT NOVA) and started her research career at iBET. During her PhD, she worked at ITQB NOVA, the John Innes Centre and the Institute of Food Research (UK). After conclusion of the doctorate (2004), she worked as a postdoctoral fellow in Microbiotechnology (3 years) and in Green Chemistry (1 year), both involving liaison and travelling between national and foreign institution.  In 2007, she was awarded an EEA research grant of nearly €1.5M, a competitive Starting Research Ciência 2007 contract and the national Professor António Xavier memorial award for young scientists. In 2008, she established her research group. In 2015, she was awarded a Consolidator Grant by the European Research Council (ERC), to develop her vision of mimicking the functionality of plant polyesters to develop wound dressing biomaterials that combine antimicrobial and skin regeneration properties. She is also a partner in a FET Project which seeks inspiration from natural aquamelts to develop new bioplastics. She is the mother of a 6-year old boy.

Topics
I will focus on my research path as the case-study to emphasise the tactics I have used for defining strategic scientific fields which would potentially led to innovation, hence funding by both private and governmental sources. I will revise concepts I have learn through experience and short training sessions in management and communication. I will expose the “dos and don’ts” sharing the reasons to have won or to have failed some important negotiations (e.g. NATO sfp, Merck, Amorins, ERC). My vision is to share my enthusiasm for science and for innovation and to communicate my research philosophy.

modules_purple.jpgM1/DAY2
SAT 15 SEP
starup_0010_Dipanjan_Nag.jpg Dipanjan Nag

Short CV

Dr. Dipanjan “DJ” Nag isis The Ohio State University’s ’sAssociate Vice President of Technology Commercialization spearheading the technology commercialization initiative for the university.

As the head of Technology Commercialization Office (TCO), his team manages 75+ active startups, which have attracted more than $190 M in capital of which 84% is private capital. At OSU, he leads the efforts for commercialization from close to a $1B research expenditure, 4,000+ patents and 2,000 technologies.

As a director at Ocean Tomo and Vice President at ICAP, he was also instrumental in helping create or lead several intellectual property exchanges. He was an entrepreneur who started several medical device companies as well as ran a predictive analytics company. As a consultant, he has worked with Fortune 500 companies advising them on monetization and intellectual property strategy. Dr.  Nag has extensive experience in global innovation and entrepreneurship having worked closely in Turkey, Poland, Japan, Brazil, Korea, India and has delivered invited keynote addresses on those topics. He also served on the board of Association for University Tech Managers (AUTM).

Topics

Understanding due diligence

o   Market

o   Technology

o   Intellectual property

o   Terms of a startup

o   Obligations of licensee

o   Obligations of licensor

o   Patent prosecution

o   Royalty

o   Milestone

o   Upfront payment

o   Claw back

o   Sublicensing

o   Market based

o   Income based

o   Cost bases

modules_grey.jpgM1/DAY3
FRI 21 SEP
starup_0004_isabel_rocha.jpg

Isabel Rocha

Short CV
Isabel Rocha is Pro-rector for Innovation and Entrepreneurship at NOVA University. During 2007 she was a visiting scholar at the Massachusetts Institute of Technology, USA, as part of the MIT-Portugal Program, where she attended several courses in innovation and entrepreneurship at the Sloan School of Management. She is part of the MIT-Portugal faculty and was, from 2007 to 2017, in charge of a Portuguese educational program in innovation involving 4 universities and 2 PhD programs – the i-teams program. She was the President of P-Bio, the Portuguese Bioindustries Association and she is also one of the founders and scientific coordinator of two companies that won several national prizes in entrepreneurship and are involved in major industrial biotechnology projects worldwide – SilicoLife and Biotempo.

Isabel does her research at ITQB-NOVA and Minho University in Biotechnology covering the topics of Metabolic Engineering and Systems Biology and has published over 120 full papers in international journals, books and international conferences. She is the Principal Investigator of several projects and is involved in collaboration projects with research institutions worldwide. She is the national representative in the European Infrastructure for Bioinformatics, the ELIXIR.

Topics
In my session, I will cover the topics of innovation in biotech using genetic modifications, focusing mostly in industrial biotechnology (bioprocess engineering) but also broadly covering other areas such as agricultural innovations.

I will discuss future trends, regulatory limitations and Intellectual property applied to those areas. I will also share with you the example of SilicoLife, a company that designs computationally microbial strains for producing a variety of bulk and specialty compounds, by performing gene deletions, gene over/under-expressions and the insertion of heterologous genes for example from plants into the microbes.

modules_grey.jpgM1/DAY3
FRI 21 SEP
startup_cecilia_arraiano.jpg

Cecília Arraiano

Short CV
Cecilia M. Arraiano graduated in Biology at the University of Lisbon. Later, she was a Fulbright Hays Fellow and obtained her PhD in Genetics from the University of Georgia, USA. Cecilia is currently a Coordinating Investigator at ITQB NOVA where she heads the Control of Gene Expression Laboratory. Cecilia’s current research interests involve the understanding of how RNA molecules control the life of the cell. More specifically, Cecilia’s team has been working on RNA degradation since this is of utmost importance to regulate protein production. Among other activities, Cecilia’s current involvement in large European Synthetic Biology projects aiming at manipulating microbial systems to set tailor-made levels of industrial products is of the highest interest to this course. During her career, Cecilia has been distinguished with several relevant Awards, for instance: Câmara Pestana /Glaxo Smith-Klein Prize, 2008; EMBO member in 2008; Portuguese Academy of Sciences in 2009; Chair of FEBS Women in Science since 2013; Fellow of the American Academy of Microbiology in 2014 and member of the European Academy of Microbiology in 2015.

Topics
Leading European and American stakeholders in the field of Synthetic Biology have been developing conceptual and technical tools that enable the engineering of prokaryotic systems with a degree of robustness and predictability that is not possible with the standard Genetic Engineering. Steps go from assembling a DNA sequence and modulating the expression of RNAs all the way to the making of the final product (e.g., an enzyme, a chemical, a reporter protein), or to the behaviour of single cells and populations. The legoization of different genetic elements plus the use of small noncoding RNAs were shown to be an excellent new tool for genetic and metabolic engineering.

Several examples will be given; for instance, in the Project “Empower Putida”, a multidisciplinary team of academic and industrial partners is cooperating in developing innovative workflows for the tailored engineering of the lifestyles of Pseudomonas putida, a bacterium with remarkable metabolic endowment and stress tolerant capabilities that make it superior to potential competitors for bespoke biocatalysis.

modules_grey.jpgM1/DAY3
FRI 21 SEP
starup_0002_ligia_martins_CSP2554.jpg

Lígia Martins

Short CV
Prof. Lígia O Martins is leading a research group focused on enzyme discovery, engineering and application in the conversion of natural and synthetic aromatics. Prof Martins is/was Principal Investigator in 9 research projects, 2 of which funded by the European Commission, and national delegate of two COST actions. Prof Martins is part of the Scientific Committee of the PhD Program in Sustainable Chemistry jointly hosted by Aveiro, Porto and NOVA Universities and of the Master Course in Biotechnology for Sustainability (ITQB NOVA) where she holds the chair of Environmental and Industrial Microbiology and Biocatalysis. She has 68 papers in high impact journals (12 with 100+ citations, three journal covers). She is/was involved in the supervision of 6 Post-docs, 9 PhD and 10 MSc students. Prof Martins is member of the Scientific Committee of the Bio-based Industries Joint Undertaking (2014-20).

Topics
Plant biomass has emerged in recent years as an extremely attractive renewable source of chemicals, materials and fuels. It is widely believed that their mere abundance can facilitate the switch to a bio-based economy and replace the petrol-based industry that we have been relied upon. However, the full development of sustainable biorefineries is critically dependent on an efficient separation and conversion of biomass constituents (cellulose, hemicellulose and lignin) in the same way petrol refineries separate oil fractions to provide diverse fuels and chemicals. Biocatalysis offers an environmentally friendly tool to disentangle recalcitrant biomass feedstocks, a top priority area in the EU and worldwide. This research is essential to support the economic health of the bio-refinery vision of the XXI century leading to increasingly knowledge-based, sustainable and inclusive economy.

modules_grey.jpgM1/DAY3
FRI 21 SEP

M1/DAY5
FRI 28 SEP

statrup_0000_TomasBaena.jpg

Tomás Baêna

Short CV
Clinical Psychologist, MA in Philosophy and MSc in Communication, Behaviour and
Credibility Analysis by Manchester Metropolitan University, Emotional Intelligence
Academy and Paul Ekman International. Director of the International Institute of Body
Language (InBodyLanguage) and Researcher at Centro de Investigação de Direito Penal
e Ciências Criminais da Faculdade de Direito da Universidade de Lisboa. Vice-President
of the Scientific and Educational Board of International School of Professional Coaching,
Credentialed Coach by International Coach Federation and NLP Trainer at Instituto
Internacional de Programação Neurolinguística. Professional Trainer with more than
8,000 hours of work experience and Guest Lecturer at Faculdade de Medicina da
Universidade de Lisboa, Universidade Fernando Pessoa and Institute of Business
Management.

Topic - Body Language Workshop
This workshop will start with the examination of the biological and phylogenetic basis
for facial expressions and body movements, as well as the leading research concerning
nonverbal language, emotions and behaviour. There will be three main pillars in this
presentation. Firstly, the description of scientific methods for the identification of basic
emotions in others through the analysis of specific facial muscles. The chief heuristics
that prevent this analysis will also be underlined. Secondly, the positive and negative
effects of the entrepreneur’s own body language on others’ perception will be
examined. The main cultural and biological biases of people’s perception concerning
body language will likewise be surveyed. Thirdly, the influence of the entrepreneur’s
own body postures on his/her behaviour will be analysed, as well as practical strategies
to enhance emotional states.

Topic - Coaching & Self-Assessment Workshop
This workshop will present an historical overview of the concept of Coaching, as well as
its primary models and applications. Four main elements will be underlined. Firstly, the
use of Coaching as a self-assessment communication tool for entrepreneurs to plan,
develop and sustain professional goals will be examined. Secondly, the chief
neurological, behavioural and linguistic features that prevent and facilitative effective
goal achievement will be described. Thirdly, the role of motivation and emotional
intelligence in behaviour change will be analysed. Finally, there will be a presentation of
several strategies and practical tools for the development of a clear, flexible and
cooperative communication in professional contexts.

modules_red.jpgM1/DAY4
SAT 22 SEP
starup_female.jpg

Isabel Borba

Short CV
available soon

Topics
available soon

modules_red.jpgM1/DAY4
SAT 22 SEP
startup__0001_Margarida Menezes.jpg

Margarida Menezes Ferreira

Short CV
Margarida Menezes Ferreira graduated in Biology at the Faculty of Sciences of the University of Lisbon. She had her PhD degree in Medical Biochemistry at the Aix-Marseille II University in France 1981 and did a post-graduate research in molecular endocrinology at the National Institutes of Health USA until 1984. She published several research papers in peer-reviewed journals amongst which two of them were selected for the Year Book of Endocrinology.

She works at INFARMED since January 1996, the Portuguese Regulatory Authority for Medicines and Health Products having developed and supervised the installation of the Biologics, Biotechnology and Microbiology Departments for the National Laboratory for the Control of Medicines and Health Products and coordinated its implementation until 2001. From 1999 to 2001 she also directed the National Control Laboratory for Medicines and Heath Products (OMCL).

Since 1999 to the present she is the appointed member for the Biologics Working Party at the European Medicines Agency (EMA). She has participated in the drafting of European guidance and scientific advice on biological medicinal products including biotechnological and biosimilars as well as gene and cell based therapies. She was member of the Cell Products Working Party until its closure and participated intensely in the construction of the regulatory framework and quality guidance for cell based medicinal products. Presently and since its establishment in 2009 she is the Portuguese member at the Committee for Advanced Therapies.

 

Topics
available soon

modules_red.jpgM1/DAY4
SAT 22 SEP

starup_0009_paula_alves.jpg

Paula Alves

Short CV
Paula Alves is CEO of iBET and Head of the Animal Cell Technology Unit at iBET and at the Instituto de Tecnologia Química Biológica (NOVA University of Lisbon) and Invited Associate Professor of Chemical and Biochemical Engineering at the Faculty of Sciences and Technology also at NOVA. Paula Alves has extensive experience in understanding cell metabolism to improve the efficiency of bioprocesses and at developing new tools and technologies for pre-clinical research. More recently this expertise was expanded to generate expansion and differentiation of stem cells in bioreactors.

The Unit she coordinates uses Animal Cell Technology for research and development in particular for (i) production of complex biopharmaceuticals such as viral vectors, vaccines and recombinant proteins (ii) development of 3D culture systems for toxicity testing using primary cells and stem cells in bioreactors (iii) expand systems biology approaches to organize the complexity of the processes involved in the research described in (i) and (ii). 

She is President of the ESACT-European Society for Animal Cell Technology and Member of the Advisory Group for Horizon 2020 Societal Challenge 1 and of the ESAC Expert Group (European Commission). Paula Alves has published over 220 papers, 29 book chapters and supervised 26 PhD students and 10 Pos-docs.

Topics
available soon

modules_green.jpgM1/DAY5
FRI 28 SEP
starup_female.jpg

Manuela Pintado

Short CV
available soon

Topics
available soon

modules_green.jpgM1/DAY5
FRI 28 SEP

startup_pedro_fevereiro_.jpg

Pedro Fevereiro

Short CV
available soon

Topics
available soon

modules_green.jpgM1/DAY5
FRI 28 SEP
starup_0012_Sofia_Tahar.jpg

Sofia Ben Tahar

Short CV
Sofia has a PhD in Animal Molecular Biology and 2 Postdoc on Plant Genetic Engineering. For 5 years Sofia was appointed as Quality Manager Director of BIOCEM, a Plant Biotechnology Laboratory for LIMAGRAIN. She has worked on Licencing In and Out the outcome results and has published patents. The implementation of New Technologies Worldwide in the company brought Sofia to build different networks and to settle a Quality Management system. Sofia has worked as an expert consultant for FAO, for Ireland Science Foundation, for EU, as legal expert. She has trained and communicated on Plant Biotechnology in different schools and Universities. Presently, Sofia is Chairing the French Standardization Body on the Methods of Detection by Molecular Biology. She is an auditor/expert for the French Accreditation Body for Agro Food laboratories and Vice Chair of expert evaluation for different EU calls.

Topics
The potential of Crop biotechnology to improve agriculture has been demonstrated since more than 21 years. It has helped achieving agriculture sustainability and development. More than 60 countries from all over the world have either planted or imported biotech crops.  Since 1996, 2 billion hectares were planted in more than 30 countries. The major growing Biotech crops are maize, cotton, soybean and canola.  The market for seeds and technologies fees have increase since 1996 from 0.1 billion$ to 15.8 billion $ in 2016. These traits have increased crop productivity, helped conserved biodiversity, reduced agriculture eco-foot print and finally have contributed to the alleviation of poverty and hunger. Recently merger between very large companies and the new gene edited crops will increase the potential market of crop biotechnology with a strong effect on agriculture development

modules_white.jpgM1/DAY6
SAT 29 SEP
startup__0005_Carlos Malpica.jpg

Carlos Malpica

Short CV
Carlos Malpica Lizarzaburu was trained in France as an Agronomic Engineer at Institut National Agronomique Paris-Grignon and Pasteur Institute and obtained his PhD in Biotechnology from Paris University 7. Additionally he holds a diploma from the Spanish Diplomatic School and an International Executive MBA from Instituto de Empresa (Spain).

Dr. Malpica is the CEO of MLP Vision Biotech S.L. and Valdia Health S.L. He is actively involved in promoting the adoption of new precision medicine tools based on multi-omics technologies. He is also the Vice-President of BioEuroLatina, a non-for-profit organization that aims at fostering the collaboration between Europe and Latin America in Biotechnology.

Past activities include Global Business Development Director and European Director at Metabolon Inc. (USA).  Marketing and Sales Director at Biopolis S.L. (Spain), Research Director at L’Oréal Group (France), CEO of Kina Biotech S.L. (Spain), Global Business Development Manager at Syngenta A.G. (Switzerland), Head of Business Development Europe at Novartis Seeds S.A.S. (France) and Biotechnology Research Coordinator at the DANONE Group (France).

Topics

“Business model for knowledge-based service life science companies”

Using the example of Valdia Health SL, Dr. Malpica will share his experience in managing innovative knowledge-based life science companies which offer services rather than products.

Valdia Health provides a multi-omics approach for convenient, state-of-the-art and actionable support to decision making in diagnostics.

The company processes samples and integrate omics data in a one-stop shop for the most advanced commercially-validated diagnostic decision-support tools including proprietary own-developed tools.
The company does not provide a diagnostic report but rather specific value-added clinically-relevant information, which will enable clinicians to produce an accurate diagnostic with potentially actionable therapeutics.

To veterinaries the company also offers ad-hoc services for their clinical needs with support from the most advanced research organizations in animal health.

modules_white.jpgM1/DAY6
SAT 29 SEP
startup__0000_Mike.jpg

Mike Jagielsky

Short CV
Mike Jagielski is a President and CEO of KCR, a contract research organization operating internationally, leading the organization for more than 5 years.  Mr. Jagielski has over 20 years of experience in global clinical trial operations industry with focus on strategic leadership for full-service and large-scale operations projects.

Under his leadership KCR has further developed to become an important market player in the CRO industry, successfully combining the company geographical coverage with strategic trial execution.

Mr. Jagielski is a thought leader defining the CRO industry trends and commenting on the business models to be adapted for successful cooperation with the pharma and biopharma industries.   

Mr. Jagielski is playing also a significant role in advocating for patient-centric approach in clinical studies. He is a seasoned presenter speaking at the main industry events e.g. Partnerships in Clinical Trials (PCT).

Prior to joining KCR he spent 13 years with Merck & Co., where he held various positions in Germany, Belgium, Finland and the U.S.

Topics
CROs are an integral part of the global pharma and biotech drug development process. CROs are providing vital research services historically focusing on the execution of Phase1 to Phase 4 clinical research projects. The business models are historically hourly based service models: different hourly rates for different level of service provision. This is very similar to other industries such as consultancy or business process outsourcing (BPO). The lecture will explain in detail the two main CRO business models and analyze advantages as well as disadvantages. In this lecture we will also review alternative business model options and judge possibility to adapt these considering the existing market forces. The controversy the CRO business model faces is that operational efficiencies would drive revenues down in an hourly business model. If CRO substantially improve efficiencies, it might lead to less financial success as CRO selection does not only depend on efficiencies. In the 90 minutes lecture we try to shine light to this controversy and will explain the basics elements of the CRO business model.

modules_white.jpgM1/DAY6
SAT 29 SEP
startup__0003_ORFEU FLORES.jpg

Orfeu Flores

Short CV
Orfeu Flores has a degree in Applied Chemistry (1992) from Universidade Nova de Lisboa, Portugal, a M.Sc. in Science and Technology Commercialization (1998) from IST-Texas University, USA; and a PhD in Molecular Genetics (2015) from Universidade Nova de Lisboa, Portugal.

Orfeu is founder and CEO of STAB VIDA (www.stabvida.com), established in 2001, a Portuguese ISO9001:2008 certified biotech SME with  30 employees and a dedicated line of products and services for genetics and genomics (http://www.stabvida.com/en/services/catalog). Its main R&D and commercialization interests are focused in point-of-care diagnostics and theragnostics (mainly for Alzheimer, Lyme and Cancer), oligo synthesis, bioinformatics and nucleic acid sequencing, including next-generation sequencing (NGS), for the biotechnology and biomedical research and clinical community.

Orfeu has a large experience in biotech entrepreneurship, having received several Entrepreneurship Awards by the Portuguese Association of Young Entrepreneurs, the Rotary Foundation and the Gulbenkian Foundation. Expert for European Commission RTD FP5, FP6, FP7 and H2020, member of several panels for project evaluation, since 1999; Project Technical Assistant for European Commission RTD FP6 in Genomics and diseases of genetic origin, since April 2000. Orfeu holds large experience in training and sequencing- methods (Sanger and NGS) as well as bioinformatics. 

Topics

A 10-line overview of each Session you are responsible for;

Innovative biotech SME's: myths and facts.

What is the difference between a Start-Up and a Spin-Off? Between a distributor and a company with its own catalogue? 

Should the Portuguese biotech (and European in general) invest in services or products? And how the digital revolution interferes with this debate?

These and other questions will be approached for both, purely academic scientists and scientists with more entrepreneurial mindsets.

modules_white.jpgM1/DAY7
FRI 12 OCT

M1/DAY8
SAT 13 OCT
starup_0007_gilgoncalves.jpg

Gil Gonçalves

Short CV
Gil Gonçalves is an Assistant Professor at the University of Porto and the Chief Scientific Officer of INOVA+. With an extensive experience in research, Gil has been involved in over 35 National and European RTD projects and has been the Principal Investigator in over 20.

Gil is also an experienced entrepreneur. Part of the team that won the Portuguese National Innovation prize (CNIBES) in 2006 with the project SeaScout, he was later involved in the project “Marine Systems and Technologies” financed by the Portuguese Innovation Agency for the creation of a high-tech spin-off based on research results. Since 2006 he was founder of 3 other high-tech based start-ups.

At the University of Porto he is responsible for the course Project Management Laboratory that involves close to 250 students from different integrated masters (4th year ) and masters programmes. This course works a Living Lab for professional skills development that brings together industry and academia, helping students to develop project management skills and team work skills while implementing concrete software development projects.

Topics
The success of projects depends not only on the technical and scientific skills necessary to perform the various research and technical activities, but also on a set of soft and management skills, such as project management skills (in its various variables of time, budget, scope, quality, resources, etc..), leadership and teamwork, as well as communication and business skills. This workshop will look into the project management body of knowledge (PMBoK) and will address the following areas of knowledge: scope management, time management, cost management, quality management, human resources management, communication management, risk management. Different methodologies (structured, agile, etc.) will be discussed and several examples from previous and/or on-going research projects will be presented. Students will be invited to develop and present the project plan for their research project.

modules_white.jpgM1/DAY8
SAT 13 OCT
starup_0005_Isabel_Motta_Mendes.jpg

Isabel Mendes

Short CV
Graduated in Public Relations and Advertising at Instituto de Novas Profissões of Lisbon, works as Copywriter since 1995. As a Copywriter trainee, was in Curitiba, Brazil, in one of the biggest agencies of the state of Paraná. Back in Portugal, worked in national agencies where developed writing skills in several communication’s disciplines, from advertising to promotional and behavioural marketing, graphic design, branding and even political marketing. In 2010, co-founded the Frank & Stein brand (closed in 2017) where developed all copywriter work and shared the creative direction. Currently, works as a freelance Copywriter for several agencies and companies and teaches Copywriting at Escola Superior de Gestão – Instituto Politécnico de Santarém (Marketing and Advertising course).

Some brands in Isabel’s portfolio: Galp Energia, Mercedes-Benz, Hyundai, CTT, Sical, Robbialac, ANA Aeroportos, L’Oréal Professionnel, Danone, Caves Aliança, Lojas Singer/Excel, Oney Bank, Fidelidade, among many others.

Topics
How can communication contribute to engage the non-scientific community with a scientific project:

1. Less is More: Communication Concepts.

The importance of summarizing a project in a couple of lines. Yes, that’s right: just a couple of lines. After all, a simple idea is easy to understand by everyone.

2. You Talkin’ To Me? Target Audiences.

How identifying the specific receivers of the message is crucial to communicate with efficiency. And how more than one target audience may require adjustments to the same message.

3. My project is your project: Message.

The time has come for a project to leave the nest. From now on it will be shared with specific audiences. What do they (each of them) want to hear? What do they value? Seduction is a game of words and the better they are used, the better are the results.

Topics
available soon

MODULE 2 | BUSINESS CONCEPTS

modules2.jpgM2/DAY1
SAT 20 OCT


M2/Day2
FRI 26 OCT

startup_bernardo_pimentel.jpg

Bernardo Pimentel

Short CV
Bernardo Melo Pimentel is an Assistant professor at Nova School of Business and Economics. He holds a Ph.D. in Management (Entrepreneurship) from Nova School of Business and Economics with B.Sc. and M.Sc. degrees from the same institution.

 His main research interests lie in the application of econometric methods to the study of entrepreneurial careers, decisions, and outcomes. This line of research evolved towards the understanding of the role of entrepreneurial ability in the market for firm acquisitions. In another project, Bernardo analyzed determinants of MNC divesture and knowledge spillovers to local employment and firm creation.

At present, Bernardo teaches Principles of Management for the undergraduate Management and Economics degrees. Additionally, he collaborates with ISEG Lisbon where he lectures for the Economics, Finance, and Management programs and with Audencia Business School where he serves as an external professor for the M&A and Strategic Alliances masters course. Previously, he was a research fellow at Instituto Superior Técnico.

Topics
available soon

modules2.jpgM2/Day3
FRI 2 NOV

M3

startup_Teresa.jpg

Teresa Mannebach

Short CV
Teresa Moana is a Mentor and Advisor in the knowledge center for Innovation and Entrepreneurship (Venture Lab) at Nova School of Business and Economics (Nova SBE). Since 2014, she is a teaching assistant for courses related to Innovation and Entrepreneurship, Family Business and Strategy Consulting at Nova SBE. She adds on to her academic knowledge with experience from being a business developer at wonkyboard.com and an entrepreneur - she launched her own business in 2014 (Slide Surfcamp). She holds a Bachelor of Science in International Business from Maastricht University and a Master in Management with specialization in Innovation and Entrepreneurship from Nova SBE. Her areas of interest include besides Innovation and Entrepreneurship, Sustainability, Ocean Health and Surfing.

Topics
available soon

modules2.jpgM2/Day4
FRI 9 NOV
M2/Day5
FRI 16 NOV

startup_anibal_lopez.jpg

Anibal López

Short CV
Aníbal is a teaching assistant of Entrepreneurship at Nova School of Business and Economics (Nova SBE). He holds a PhD in Management (Entrepreneurship) from Nova SBE. Aníbal previously worked as researcher assistant in different research projects in organizational behavior field. His main research interests focus obstacles to entrepreneurship, entrepreneurial passion and new venture management. He is the current responsible for the academic programs of the Nova SBE’s Innovation and Entrepreneurship knowledge center (Venture Lab).

Topics
available soon

modules2.jpgM2/Day6
FRI 23NOV
startup_fabio_santos.jpg

Fábio Santos

Short CV
Fábio Santos is an Assistant Professor (Adjunct) at Nova School of Business and Economics. He currently teaches Finance in the Undergraduate program. In the past he conducted theoretical classes in Finance, Statistics, and Problem Solving. He has also been a teaching assistant for Calculus, Accounting, Macroeconomics Principles (among others).

He has a Master’s degree in Finance from Nova School of Business and Economics and an Undergraduate degree from the same University.

Besides the academic experience, Fábio holds a business career at Sonae after his consulting experience at AT Kearney and in Nova SBE projects.

Topics
available soon

modules2.jpgM2/Day7
FRI 30 NOV
startup_miguel_munoz.jpg

Miguel Muñoz

Short CV
He is the Executive Director of Nova School of Business and Economics Venture Lab (Nova SBE Entrepreneur and Innovation center), established in 2017. Since 2014, he works as an Assistant Professor at Nova School of Business and Economics (teaches entrepreneurship to undergraduate and master's degrees). Miguel is an entrepreneur with several businesses launched (until 2008 a Strategic Marketing Agency and since 2008 an Innovation and Creativity Consultancy). Since 2014, he is also an Invited Mentor, Lecturer and Speaker for several incubators and acceleration programs. From 1999 to 2004 he was the Marketing Manager and Senior Marketeer at DANONE PORTUGAL / DANONE MEXICO, and from 1997 to 1999 he was a Marketeer at HENKEL IBÉRICA. Miguel holds an Economic Degree from NOVA SBE and Master in Entrepreneurship and Innovation from ISCTE-IUL.

Topics
available soon

MODULE 3 | START-UP PROJECT DEVELOPMENT

modules3.jpgM3 startup__0004_Duarte Oliveira.jpg

Duarte Oliveira

Short CV

PROFESSIONAL EXPERIENCE

2015 – 2018        KAM Strategic Project Manager, Public Affairs & Market Access Department, Novartis, Portugal

2014 – 2015        Medical Affairs Project Manager, Medical Department, Novartis Portugal

2008 – 2012        Principal Investigator & Group Leader, FCT/UNL, Caparica, Portugal

2007 – 2010        Independent Expert, Research Projects Evaluator, European Commission, Belgium

2003 – 2008        Invited Assistant Professor, Escola Superior de Biotecnologia, UCP, Caldas da Rainha, Portugal

2002 – 2007        Post-doc fellow, ITQB/UNL, Oeiras, Portugal  (Portugal)


1996 – 2001        PhD student, ITQB/UNL; Oeiras, Portugal & The Rockefeller University, New Work, NY,  USA

 

EDUCATION

  • MBA, The Lisbon MBA International, Católica | Nova | MIT Sloan, Lisbon, Portugal and Boston, USA, 2013.
  • PhD in Biology/Molecular Biology, ITQB/UNL, Oeiras, Portugal, 2002 

  • MSc in Applied Chemistry/Biotechnology, FCT/UNL, Caparica, Portugal, 1995

Topics
available soon

modules3.jpgM3 starup_0008_Helder Cruz.jpg

Helder Cruz

Short CV

Helder Cruz has a 5- year degree in Applied Chemistry (branch of Biotechnology) from FCT-UNL, an MBA in International Businesses from Univ Católica Portuguesa and a PhD in Biochemical Engineering from ITQB-UNL. After getting the PhD degree, the applicant had several activities (some in parallel):

- Post-doc at the GLP Lab at IBET in the development of cell-based assays;

- Senior researcher started at Biosensors Lab from ITQB-UNL; has authored several publications as well as co-supervised master and PhD students;

- Consultant for biopharmaceutical companies (US, EU and PT). He was member of a Board of Directors and of Scientific Advisory Boards;

- Invited professor of Bioengineering for a MSc Program (ESSCVP, Lisbon) and of Biochemistry, Enzymology, Molecular and Cellular Biology (UnI, Lisbon)

- Evaluator and reviewer of research projects financed by the European Commission

- Co-founder two knowledge-based biotech companies, ECBio and Theraproteins.

Topics
available soon

modules3.jpgM3 starup_0000_nuno_simoes.jpg

Nuno Simões

Short CV
Nuno is a Nova SBE Management Alumni. Business Consultant and Executive Coach. Serial Entrepreneur with a main focus on child development and entrepreneurship. Presently running the franchise network for both Portugal and Brasil of Gymboree Play and Music – The world leader in classes for kids.  Organizer of the Lemonade Festival. He believes entrepreneurship is a discipline that can be taught – going from problem to solution to implementation to sustainability is like going from data to information to knowledge to wisdom and insight. He has also been investing and mentoring several startups and entrepreneurships accelerating programs.  

Topics
available soon

modules3.jpgM3 starup_male.jpg

Pedro Cruz

Short CV
Pedro Cruz graduated in Chemical Engineering – Biotechnology branch at the Instituto Superior Técnico da Universidade de Lisboa, holds a PhD in Biochemical Engineering from Instituto de Tecnologia Química Biológica da Universidade Nova de Lisboa and a Masters in Business Administration (MBA) in International Management from the Universidade Católica de Lisboa.

Working in Animal Cell Technology since 1992 at iBET and until October 2011, he was involved in the start-up of iBET’s Pilot Plant, and performed research in the fields of viral vaccines and gene therapy for almost 20 years. He was one of the founders of ECBio, S.A., a company devoted to the development of cell-based therapies, and its Chief Scientific Officer from 2003 to 2017. Within this role he has also been responsible for the management of the company and definition of company’s business plans including negotiations with investors. He is also Assistant Professor at the Atlântica School of Management Sciences, Health, IT & Engineering since 2000 where he teaches project valuation, strategic management and entrepreneurship to management, IT and healthcare courses. He is Chief Technical Operations Officer at IBET since January 2018.

Topics
available soon

modules3.jpgM3 startup_Joana_Lobo_Antunes.jpg Joana Lobo Antunes

Short CV
Joana Lobo Antunes is a post-doctoral researcher in science communication at ITQB and CIMJ (FCSH). She has a degree in Pharmaceutical Sciences (University of Lisbon) and a PhD in Organic Chemistry (University of Santiago de Compostela) and since 2004 has been teaching at Universidade Lusófona. Her interest in theatre, led her to study Forum Theatre with Augusto Boal, Julián Boal, Armindo Pinto and Gisella Mendoza, and to perform with Grupo de Teatro do Oprimido de Lisboa (2006-2008). Combining her passions for science and theatre, Joana applied theatrical improvisation techniques to develop oral communication and voice/posture workshops for university professors and science communication students, and has co-directed scientists in a theatre play about scientist’s lives and conflicts (staged at Gulbenkian, Teatro Municipal de Bragança, Teatro Nacional D. Maria II, among others). In 2009, she founded CQD, a non for profit cultural association devoted to linking Science and Theater.

Topics
available soon

modules3.jpgM3 starup_male.jpg Luís Morgado

Short CV
available soon

Topics
available soon